File(s) under permanent embargo
Tumoricidal effects of the JAK inhibitor Ruxolitinib (INC424) on hepatocellular carcinoma in vitro
journal contribution
posted on 2013-01-01, 00:00 authored by G Wilson, A Tian, L Hebbard, Wei DuanWei Duan, J George, X Li, L QiaoTumoricidal effects of the JAK inhibitor Ruxolitinib (INC424) on hepatocellular carcinoma in vitro
History
Journal
Cancer lettersVolume
341Issue
2Pagination
224 - 230Publisher
ElsevierLocation
Amsterdam, The NetherlandsPublisher DOI
ISSN
0304-3835eISSN
1872-7980Language
engPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2013, ElsevierUsage metrics
Categories
No categories selectedKeywords
RuxolitinibHepatocellular carcinomaJAK signallingScience & TechnologyLife Sciences & BiomedicineOncologySQUAMOUS-CELL CARCINOMAJAK\/STAT PATHWAYGROWTH-FACTORCANCER-CELLSCONSTITUTIVE ACTIVATIONDEPENDENT ANGIOGENESISLIVER INFLAMMATIONSTAT3 ACTIVATIONTUMOR-GROWTHINCB018424HCCINC424Ruxolitinib (INC018424)